Literature DB >> 9523237

Monitoring of PPAR alpha protein expression in human tissue by the use of PPAR alpha-specific MAbs.

J L Su1, C J Simmons, B Wisely, B Ellis, D A Winegar.   

Abstract

We report the production and characterization of two PPAR alpha subtype-specific monoclonal antibodies raised against the N-terminal domain of PPAR alpha. P alpha b 11.80A is a Western-reactive antibody, whereas P alpha b 32.51 is useful for immunohistochemistry. Both antibodies exhibited high affinity against the immunogen based on BIAcore analysis, recognized full-length PPAR alpha protein in PPAR alpha-transfected CV-1 cells, and displayed no cross-reactivity against the N-terminal domains of PPAR gamma or PPAR delta proteins as demonstrated by various immunoassays. The application of these antibodies to a panel of normal human tissues revealed that PPAR alpha protein expression is highest in skeletal muscle, liver, and kidney, consistent with previously reported mRNA expression data. These antibodies provide us with valuable tools to further explore the function of PPAR alpha.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9523237     DOI: 10.1089/hyb.1998.17.47

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  7 in total

1.  Coordinately regulated expression of FAT/CD36 and FACS1 in rat skeletal muscle.

Authors:  J J Luiken; X X Han; D J Dyck; A Bonen
Journal:  Mol Cell Biochem       Date:  2001-07       Impact factor: 3.396

2.  Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus.

Authors:  R Rahimian; E Masih-Khan; M Lo; C van Breemen; B M McManus; G P Dubé
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

3.  Plasma triglycerides are not related to tissue lipids and insulin sensitivity in elderly following PPAR-alpha agonist treatment.

Authors:  Melanie G Cree; Bradley R Newcomer; Laura K Read; Melinda Sheffield-Moore; Douglas Paddon-Jones; David Chinkes; Asle Aarsland; Robert R Wolfe
Journal:  Mech Ageing Dev       Date:  2007-08-15       Impact factor: 5.432

4.  Peroxisome proliferator-activated receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes.

Authors:  Veerle Reynders; Stefan Loitsch; Constanze Steinhauer; Thomas Wagner; Dieter Steinhilber; Joachim Bargon
Journal:  Respir Res       Date:  2006-07-30

Review 5.  Biology of senescent liver peroxisomes: role in hepatocellular aging and disease.

Authors:  J Youssef; M Badr
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

6.  Peroxisome proliferator-activated receptors in diabetic nephropathy.

Authors:  Shinji Kume; Takashi Uzu; Keiji Isshiki; Daisuke Koya
Journal:  PPAR Res       Date:  2009-03-04       Impact factor: 4.964

7.  Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control.

Authors:  Jihan Youssef; Mostafa Badr
Journal:  J Biomed Biotechnol       Date:  2004
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.